Profile data is unavailable for this security.
About the company
Novozymes A/S is a Denmark-based biotechnology company engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. The Company operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. It develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Bayer and Syngenta in Agriculture and DSM and Adisseo in Animal Health & Nutrition..
- Revenue in DKK (TTM)31.05bn
- Net income in DKK4.36bn
- Incorporated2000
- Employees11.64k
- LocationNovozymes A/SKrogshoejvej 36BAGSVAERD 2880DenmarkDNK
- Phone+45 44460000
- Fax+45 44469999
- Websitehttps://www.novozymes.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Symrise AG | 37.26bn | 3.79bn | 79.88bn | 12.98k | 21.07 | 2.88 | 13.15 | 2.14 | 3.63 | 3.63 | 35.73 | 26.57 | 0.6377 | 2.39 | 4.88 | 392,117.30 | 6.53 | 5.14 | 8.00 | 6.09 | 40.57 | 37.93 | 10.24 | 8.38 | 0.8274 | 13.00 | 0.3927 | 41.53 | 5.67 | 7.96 | 40.46 | 10.14 | 6.85 | 4.78 |
| Yara International ASA | 99.64bn | 8.73bn | 83.36bn | 17.00k | 9.55 | 1.50 | 5.33 | 0.8366 | 51.35 | 51.35 | 586.44 | 327.44 | 0.9724 | 3.49 | 9.56 | -- | 8.53 | 5.54 | 11.01 | 7.35 | 28.29 | 26.43 | 8.78 | 5.39 | 0.8859 | -- | 0.3237 | 72.01 | 12.66 | 6.15 | 9,671.43 | 14.64 | 4.59 | -14.05 |
| Ems Chemie Holding AG | 16.43bn | 3.79bn | 120.76bn | 2.76k | 31.87 | 7.10 | 28.36 | 7.35 | 19.75 | 19.75 | 85.69 | 88.60 | 0.8193 | -- | 5.92 | 709,534.40 | 19.08 | 22.10 | 21.80 | 26.30 | -- | 44.96 | 23.29 | 22.82 | 4.52 | -- | 0.0117 | 87.59 | -5.40 | -0.7734 | 0.7015 | -2.65 | -12.19 | -4.12 |
| Novozymes A/S | 31.05bn | 4.36bn | 154.54bn | 11.64k | 40.00 | 2.14 | 17.86 | 4.98 | 9.32 | 9.32 | 66.41 | 174.01 | 0.2636 | 2.57 | 5.77 | 2,667,418.00 | 3.70 | 6.22 | 4.21 | 7.37 | 53.91 | 52.87 | 14.04 | 15.01 | 0.4418 | 12.04 | 0.2168 | 55.38 | 8.45 | 17.20 | 90.84 | 9.01 | 30.14 | 4.32 |
| Sika AG | 91.88bn | 8.56bn | 207.18bn | 33.71k | 24.20 | 3.79 | 15.92 | 2.26 | 6.50 | 6.50 | 52.35 | 41.49 | 0.7198 | 3.90 | 5.35 | 332,313.80 | 6.72 | 8.50 | 8.37 | 10.57 | 54.94 | 52.95 | 9.33 | 10.32 | 0.8998 | 10.83 | 0.4529 | 32.89 | -4.78 | 7.29 | -16.18 | 4.83 | 23.31 | 8.16 |
Data as of Mar 03 2026. Currency figures normalised to Novozymes A/S's reporting currency: Danish Krone DKK
16.84%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 04 Feb 2026 | 13.09m | 3.16% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 11.12m | 2.68% |
| Pictet Asset Management SAas of 06 Feb 2026 | 7.94m | 1.92% |
| BlackRock Fund Advisorsas of 06 Feb 2026 | 6.02m | 1.45% |
| BlackRock Investment Management (UK) Ltd.as of 27 Feb 2026 | 5.72m | 1.38% |
| Fidelity Management & Research Co. LLCas of 31 Dec 2025 | 5.60m | 1.35% |
| APG Asset Management NVas of 31 Dec 2024 | 5.55m | 1.34% |
| Impax Asset Management Ltd.as of 30 Jan 2026 | 5.51m | 1.33% |
| Comgest SAas of 31 Dec 2025 | 5.30m | 1.28% |
| Geode Capital Management LLCas of 26 Feb 2026 | 3.97m | 0.96% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
